Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
409
-
Total 13F shares, excl. options
-
24.1M
-
Shares change
-
-1.44M
-
Total reported value, excl. options
-
$5.13B
-
Value change
-
-$275M
-
Put/Call ratio
-
1.22
-
Number of buys
-
190
-
Number of sells
-
-182
-
Price
-
$212.41
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q4 2022
450 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q4 2022.
Medpace Holdings, Inc. - Common Stock (MEDP) has 409 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.1M shares
of 30.9M outstanding shares and own 78.22% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.16M shares), VANGUARD GROUP INC (2.7M shares), WASATCH ADVISORS INC (1.64M shares), FULLER & THALER ASSET MANAGEMENT, INC. (938K shares), STATE STREET CORP (830K shares), Invesco Ltd. (592K shares), DIMENSIONAL FUND ADVISORS LP (591K shares), GEODE CAPITAL MANAGEMENT, LLC (586K shares), Boston Trust Walden Corp (547K shares), and RIVERBRIDGE PARTNERS LLC (456K shares).
This table shows the top 409 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.